DNA and genetic testing are big business. But there are real questions about privacy and about what happens to your genetic information after you get tested. Recently, the DNA testing company 23andMe partnered with pharmaceutical giant GlaxoSmithKline to develop personalized drugs and research treatment for diseases like lupus and Parkinson's. Jen King is director of consumer privacy at the Center for Internet and Society at Stanford Law School. King told Marketplace Tech's Molly Wood that, surprisingly, most people who take DNA tests don't think the data is all that personal. (10/16/18)
DNA and genetic testing are big business. But there are real questions about privacy and about what happens to your genetic information after you get tested. Recently, the DNA testing company 23andMe partnered with pharmaceutical giant GlaxoSmithKline to develop personalized drugs and research treatment for diseases like lupus and Parkinson’s. Jen King is director of consumer privacy at the Center for Internet and Society at Stanford Law School. King told Marketplace Tech’s Molly Wood that, surprisingly, most people who take DNA tests don’t think the data is all that personal. (10/16/18)
The future of this podcast starts with you.
Every day, the “Marketplace Tech” team demystifies the digital economy with stories that explore more than just Big Tech. We’re committed to covering topics that matter to you and the world around us, diving deep into how technology intersects with climate change, inequity, and disinformation.
As part of a nonprofit newsroom, we’re counting on listeners like you to keep this public service paywall-free and available to all.
Support “Marketplace Tech” in any amount today and become a partner in our mission.
